APA (7th ed.) Citation

Hatletvedt, N. D., Engebrethsen, C., Geisler, J., Geisler, S., Aas, T., Lønning, P. E., . . . Knappskog, S. (2025). The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapy. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-13675-2

Chicago Style (17th ed.) Citation

Hatletvedt, Nora D., Christina Engebrethsen, Jürgen Geisler, Stephanie Geisler, Turid Aas, Per E. Lønning, Liv B. Gansmo, and Stian Knappskog. "The Impact of Functional MDM2-polymorphisms on Neutrophil Counts in Breast Cancer Patients During Neoadjuvant Chemotherapy." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-13675-2.

MLA (9th ed.) Citation

Hatletvedt, Nora D., et al. "The Impact of Functional MDM2-polymorphisms on Neutrophil Counts in Breast Cancer Patients During Neoadjuvant Chemotherapy." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-13675-2.